[Noninvasive Respiratory Support for Novel Coronavirus Pneumonia: Enough is Enough]

C Pan; W Zhang; J A Xia; H Liu; B Du; H B Qiu

doi:10.3760/cma.j.issn.0578-1426.2020.0006

[Noninvasive Respiratory Support for Novel Coronavirus Pneumonia: Enough is Enough]

Zhonghua Nei Ke Za Zhi. 2020 Mar 4;59(0):E006. doi: 10.3760/cma.j.issn.0578-1426.2020.0006. Online ahead of print.

[Article in Chinese]

Authors

C Pan¹, W Zhang², J A Xia³, H Liu⁴, B Du⁵, H B Qiu¹

Affiliations

¹ Department of Critical Care Medicine, Zhongda Hospital, Southeast University, Nanjing 210009,China.
² Department of Emergency,900th Hospital of Joint Service Corps, PLA, Fuzhou 350025, China.
³ Department of Critical Care Medicine, Wuhan Jinyintan Hospital, Wuhan 430013, China.
⁴ Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022, China.
⁵ Medical Intensive Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.

PMID: 32129582
DOI: 10.3760/cma.j.issn.0578-1426.2020.0006

Abstract

新型冠状病毒易导致急性呼吸窘迫综合征(ARDS)，已对生命安全构成极大的威胁。无创呼吸辅助治疗是新型冠状病毒肺炎引起ARDS的常规治疗手段，但在新型冠状病毒肺炎治疗中，往往存在过度使用无创呼吸功能支持治疗而导致气管插管延迟进而影响患者的临床预后，因此，了解无创通气使用的指征和禁忌，早期识别无创通气治疗失败的危险因素，适时终止无创通气转为有创通气是目前临床医师治疗新型冠状病毒肺炎亟需关注的问题。.